Lidocaine Patch 5%
- 1 February 2000
- journal article
- Published by Springer Nature in Drugs
- Vol. 59 (2) , 245-249
- https://doi.org/10.2165/00003495-200059020-00006
Abstract
▴ Lidocaine patch 5% comprises a soft, stretchy adhesive patch ( 10 by 14cm) containing 5% lidocaine (700mg) for the topical treatment of pain associated with postherpetic neuralgia (PHN). ▴ Lidocaine provides analgesic relief by blocking neuronal sodium channels. ▴ Systemic absorption from lidocaine patch 5% is minimal in healthy subjects and patients with postherpetic neuralgia (3% of the dose is absorbed). ▴ In clinical trials (conducted over 12 hours to 24 days) involving patients with allodynia associated with PHN, treatment with lidocaine patch 5% resulted in a significant reduction in pain intensity and increased pain relief compared with vehicle patch. ▴ Lidocaine patch 5% was associated with few adverse events, the most frequent being mild skin redness or irritation at the application site which occurred with a similar incidence with lidocaine and vehicle patch.Keywords
This publication has 16 references indexed in Scilit:
- A Trial of Intravenous Lidocaine on the Pain and Allodynia of Postherpetic NeuralgiaJournal of Pain and Symptom Management, 1999
- Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment studyPublished by Wolters Kluwer Health ,1999
- The management of postherpetic neuralgiaPublished by Oxford University Press (OUP) ,1997
- Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgiaPain, 1996
- Systemic lidocaine silences ectopic neuroma and DRG discharge without blocking nerve conductionPublished by Wolters Kluwer Health ,1992
- Post-herpetic neuralgia: Further post-mortem studies of cases with and without painPain, 1991
- Post-herpetic neuralgia: the relation of pain complaint, sensory disturbance and skin temperaturePain, 1989
- Topical lidocaine reduces pain in post-herpetic neuralgiaPain, 1989
- The effect of intravenous lidocaine, tocainide, and mexiletine on spontaneously active fibers originating in rat sciatic neuromasPain, 1989
- Clinical Pharmacokinetics of LignocaineClinical Pharmacokinetics, 1978